Single cell transcriptome data from meningioma tissues.
Release date:
Meningioma was proposed as a diagnosis through imaging studies and was later verified by post-surgery pathology reports. The patients who participated in the study all gave written informed consent, and the ethical review board of Beijing Tiantan Hospital, Capital Medical University (KY2017-022-01) approved the study protocols.The scRNA-seq experiment was conducted at CapitalBio Technology Co., Ltd. In brief, the single-cell suspension was loaded onto the 10X Genomics single-cell chip with the goal of capturing 3000 cells/chip. The library was prepared according to the recommended protocol of the 10X Genomics Single Cell 3' Kit. The sequencing library was constructed using single-cell 3' v2 chemistry (10x Genomics) and sequenced on Illumina HiSeq X-10, generating 90 G data for each sample. The raw sequencing data underwent processing by Cell Ranger (version 3.02), which is the official bundled software of 10X Genomics. We aligned the data to the human reference genome (GRCh38) using the default pipeline.
Data Accessibility:   
Controlled access Request Data
Study type:
Disease Study
Disease name:
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.

DAC name:
DK Research Group
Contact person:
Zhang Dake
Beihang University ,Biological Science and Medical Engineering ,DK Research Group
Individuals & samples
Submitter:   Zhang Dake /
Organization:   Beihang University
Submission date:   2023-06-15
Requests:   4